drugset / Trial / NCT04830397
Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Evaluating the safety and tolerability of QLS-101 versus timolol maleate ophthalmic solution in glaucoma or ocular hypertension.
Timeline
- Start
- 2021-03-31
- Primary completion
- 2022-02-17
- Completion
- 2022-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS-101 | Unknown | 0.5 % | Other |
| Subject | QLS-101 | Unknown | 1 % | Other |
| Subject | QLS-101 | Unknown | 2 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |